Our Vision

Our vision for Clarion is to build the world’s leading biopharmaceutical strategy consultancy. Our aim is to deliver superior strategic insights and organizational improvements. Through our team of seasoned professionals who draw from diverse backgrounds, we tackle our clients’ most complex business challenges. In addition, we deliver fit-for-purpose strategies, insights and blueprints for organizational change. Our reach is broad; our network extensive. We assemble supremely talented teams to work side-by-side with your teams to deliver results.

Our secondary vision is to build a firm that attracts, develops and generates leaders in the life sciences industry. We are committed to developing executive-level skills in our staff through extensive coaching and diverse project experiences. While many will choose to stay with us for the long-term, others will build off their Clarion experiences and step into senior leadership positions across the biopharmaceutical industry. An experience at Clarion positions our alumni for leadership succss regardless of their career path.

Clarion Values

Clarion is solely focused on making a positive IMPACT on our clients’ future as well as patients’ health. This is what motivates us every day. We share and seek a set of core values that are key to our success:

  • Passion – the unyielding force that drives our people to complete the job no matter what obstacles emerge
  • Inquisitiveness – the embedded interest in going deep and moving beyond observation to meaningful insight
  • Collaboration – the confidence to listen, explore and build superior solutions together
  • Honesty – the courage to say what you think, especially when the perspective may be unpopular

Our History


Clarion’s founders meet at the Boston Marriott Long Wharf Hotel to discuss a vision for a firm dedicated to its clients' successes. After a week-long brainstorming session and months of planning, Clarion moves into its first office, 101 Federal Street, in September.


Clarion moves to 303 Congress Street.


Clarion reaches the 25 employee mark and expands to One Beacon Street.


Clarion moves to 99 Summer St, its first office in Boston's Financial District.


Clarion adds its first new managing director, Carol Kearney, and expands further to One Financial Center.


Clarion promotes Dennis Chang to principal.


Clarion promotes Bobby Moy to principal; Clarion hosts its first firm off-site in Chatham, MA.


Clarion extends to 75% of the 16th floor at One Financial Center to accommodate the growing firm. Clarion also hosts its first "CoNNCT" workshop with industry, academic and FDA leaders to discuss novel/novel drug development.


Clarion passes the 50 employee mark. Clarion also holds its first annual, two-day PROPEL workshop to introduce advanced degree candidates to the firm.


Clarion adds its second new managing director, Dominick Mastropoalo; Clarion promotes Jen Fennessy to director of finance and operations.


Clarion promotes Alyssa Trigger to principal; Clarion co-founder Dan Hawkins retires and becomes first member emeritus.


Clarion adds two new managing directors, Dennis Chang and Bobby Moy; Clarion announces new equity partnership with Svoboda Capital Partners.


Clarion passes the 60 employee mark and moves to 280 Summer Street; Clarion promotes Natalie Thovmasian to principal, hires Tim Barder as a senior principal and David Bower as a principal; Mark Altmeyer is elected to Clarion’s Board of Directors.


Is Clarion the right place to advance your career?

Find out more about joining Clarion’s team of innovation advisors.

A life sciences strategy and organizational consultancy that collaborates with its clients to envision, craft and enable growth through innovation and leadership.